Delusion at the top - Anonymous employee Sano Genetics Employee Review

I really care about Sano’s mission and what we’re trying do to improve the lives of patients but after so much time working here it’s been so disappointing. I still want Sano to do well, but I hardly see any evidence of us improving the lives of patient

 This company is a mirage. It markets itself as a game-changer in patient recruitment for clinical trials, but the reality couldn’t be further from the truth. The product is an absolute joke—outdated, broken, and virtually useless. And it’s been that way for years. Leadership knows it, but they refuse to acknowledge how much it lacks basic functionality, let alone fix them. They continue to lie to themselves about what the product does. The only reason clients stick around is because of the relationships built with them It has nothing to do with the product. 
The CTO’s leadership, in particular, is a major liability and his inexperience as we’ve scaled is so evident, it’s quite sad really. 

 There’s no coherent product strategy, and the product team suffers from a lack of direction and accountability. Feature requests—essential for meeting client needs—languish for months or even years. The CTO’s arrogance, inexperience and lack of judgement refuse to address the team’s and his own shortcomings which exacerbate the problem. This stifles any hope for innovation or progress. Despite the team’s best efforts to maintain client relationships, leadership remains deluded, believing the product itself is a selling point. It’s not. Clients stay because of personal connections, not because the product delivers results. In fact, across an entire year, we've managed to refer something like two patients to clinical trials—a glaring failure given its our supposed mission. 
 What’s worse is the company’s willingness to mislead clients about its capabilities and timelines about when features will get built. There is no product worthy of the name, and clients are sold an illusion of functionality and impact. This lack of transparency really damages trust internally and with clients. For any VCs considering an investment: tread carefully. Without substantial changes to leadership, product strategy, and delivery, this company is on very shaky ground. If you’re looking for returns, you’d likely be better off betting on Dogecoin.